Doxycycline, a widely used antibiotic in dermatology with a possible anti‐inflammatory action against <scp>IL</scp> ‐6 in <scp>COVID</scp> ‐19 outbreak

COVID-19: consider cytokine storm syndromes and immunosuppression

Puja Mehta, Daniel F. McAuley, Michael Brown et al. · The Lancet · 2020 · 10.2K citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · International Journal of Antimicrobial Agents · 2020 · 5K citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +10

Anti‐Inflammatory Properties of Low and High Doxycycline Doses: An <i>In Vitro</i> Study

Roberta Di Caprio, Serena Lembo, Luisa Di Costanzo et al. · Mediators of Inflammation · 2015 · 135 citations · Full text

Life Sciences, Immunology, Pharmacology +17

COVID‐19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action

Claudio Conforti, Roberta Giuffrida, Caterina Dianzani et al. · Dermatologic Therapy · 2020 · 102 citations · Full text

Medicine, Dermatology, Pharmacotherapy +12

Abnormal Weight Gain and Gut Microbiota Modifications Are Side Effects of Long-Term Doxycycline and Hydroxychloroquine Treatment

Emmanouil Angelakis, Matthieu Million, Jean‐Christophe Lagier et al. · Antimicrobial Agents and Chemotherapy · 2014 · 97 citations · Full text

Life Sciences, Microbiology, Pharmacology +16